Recognizing strength in numbers, three prominent New England cancer centers are forming a research consortium to advance cancer prevention, detection and treatment.
UMass Memorial Cancer Center of Excellence, Dartmouth-Hitchcock Norris Cotton Cancer Center in New Hampshire and the Vermont Cancer Center at the University of Vermont are working together to unlock the secrets of cancer cells. In its initial year, the collaborative is funding six grants chosen from a pool of 20 applications.
“Cancer prevention, detection and treatment are formidable challenges,” said Gary Stein, PhD, the Gerald L. Haidak, MD, and Zelda S. Haidak Professor of Cell Biology, co-director of the UMass Memorial Cancer Center of Excellence and chair and professor of cell biology. “It would be difficult to overstate the opportunities for progress that will emerge by combining the unique expertise and experience of three major northern New England cancer centers. Unquestionably, this collaborative team approach will exceed advances that can be made independently.”
Stein said the objective is to support basic, clinical, population-based and translational cancer research. Physician-investigators in the program are required to work with at least one other institution. Funding is approved for the first year of study, with a second year available for researchers who demonstrate outstanding progress and seek outside funding for subsequent years.
The Our Danny Cancer Fund is funding the work of the UMass Medical School and UMass Memorial researchers.
“This is a window of opportunity that will enable the dedicated members of three leading cancer centers to make a difference that can save lives,” said Dottie Manning, co-founder of the Our Danny Cancer Fund.
Research initiatives of the collaborative program include:
UMMS and Dartmouth scientists will partner to understand disruption of relationships between cell division and blood cell formation that occurs during development of leukemia.